Pre-Clinical Evaluation of CD38 Chimeric Antigen Receptor Engineered T Cells for the Treatment of Multiple Myeloma
Haematologica - Italy
doi 10.3324/haematol.2015.137620
Full Text
Open PDFAbstract
Available in full text
Categories
Date
February 8, 2016
Authors
Publisher
Ferrata Storti Foundation (Haematologica)